{"url_path":"/sec/crvo/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 **","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","accession_number":"0001437749-26-017236","cik":"0001053691","ticker":"CRVO","issuer_name":"CervoMed Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1053691/0001437749-26-017236-index.html","primary_entity_key":"0001053691","primary_entity_name":"CervoMed Inc."},"word_count":270,"has_tables":true,"body_markdown":"**ITEM 6.**\n\n**EXHIBITS**\n\n \n\nExhibit No.\n\nDescription\n\nMethod of Filing\n\n \n \n \n\n31.1\n\n[Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)](ex_963415.htm)\n\nFiled herewith.\n\n31.2\n\n[Certification of the Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)](ex_963416.htm)\n\nFiled herewith.\n\n32.1\n\n[Certification of Principal Executive Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b)](ex_963417.htm)\n\nFurnished herewith.\n\n32.2\n\n[Certification of Principal Financial Officer pursuant to Rule 13a-14(b) or Rule 15d-14(b)](ex_963418.htm)\n\nFurnished herewith.\n\n101.INS*\n\nInline XBRL Instance Document\n\nFiled herewith.\n\n101.SCH*\n\nInline XBRL Taxonomy Extension Schema Document\n\nFiled herewith.\n\n101.CAL*\n\nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\nFiled herewith.\n\n101.DEF*\n\nInline XBRL Taxonomy Extension Definition Linkbase Document\n\nFiled herewith.\n\n101.LAB*\n\nInline XBRL Taxonomy Extension Label Linkbase Document\n\nFiled herewith.\n\n101.PRE*\n\nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\nFiled herewith.\n\n104\n\nCover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101)\n\nFiled herewith.\n\n \n\n* XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections.\n\n \n\n27\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\n \n \n\n**CervoMed Inc.**\n\n \n \n \n \n\nDate: May [15], 2026\n\nBy:\n\n/s/ John Alam\n\n \n\n \n\n \n\nJohn Alam\n\n \n\n \n\n \n\nPresident and Chief Executive Officer\n\n \n\n \n\n \n\n(Principal Executive Officer)\n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n\nDate: May [15], 2026\n\nBy:\n\n/s/ William Elder\n\n \n\n \n\n \n\nWilliam Elder\n\n \n\n \n\n \n\nChief Financial Officer and General Counsel\n\n \n\n \n\n \n\n(Principal Financial Officer)\n\n \n\n \n\n28"}